Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, November 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Metabolon Announces Quantose IR Test Launched in Mexico
Friday, June 06, 2014
Quantose IR™ test available through PATIA Biopharma to help prevent type 2 diabetes.

New XFe96 Spheroid Microplate from Seahorse Bioscience
Tuesday, April 22, 2014
The microplate enables functional, metabolic measurement of in vitro tumor spheroids.

Metabolon Launches Fourth Generation DiscoveryHD4™ Metabolomics Platform
Saturday, April 05, 2014
New technology advancements have potential to lead the way to new scientific breakthroughs, novel biomarkers and discoveries, and support diagnostic product pipeline.

Waters Progenesis QI Marks Next Generation of LC-MS 'Omics Analysis
Friday, April 04, 2014
Company unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics at Analytica.

AbsoluteIDQ® p180 by BIOCRATES Life Sciences AG
Tuesday, March 25, 2014
Cutting-edge test kit made in Austria helps develop the world’s first metabolomics-based blood test to predict Alzheimer’s disease.

Hepregen Launches First Human HepatoPac™ Assay Kit
Thursday, March 13, 2014
Application-directed kit provides accurate information to developers of pharmaceuticals, cosmetics, and all new chemical entities.

New Website Set to Become a Valuable Resource for Gas Chromatographers
Wednesday, February 26, 2014
The Markes International website includes new application-specific content, improved navigation, and an enhanced online shop.

Waters Introduces UPLC System for nano- to Microscale Separations
Wednesday, January 29, 2014
New UPLC system and columns drive separations efficiency and the sensitivity of LC-MS analyses to new levels.

Analytik Jena Develops Innovative Technology
Monday, January 13, 2014
Highly efficient enrichment of free-circulating DNA.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 334
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv